Production of biopharmaceutical proteins by yeast: advances through metabolic engineering.
about
Genetically modified proteins: functional improvement and chimeragenesisCell factories for insulin productionAvian embryos and related cell lines: A convenient platform for recombinant proteins and vaccine production.Production of recombinant human proinsulin in the milk of transgenic mice.Genome-scale modeling of the protein secretory machinery in yeastBuilding a bio-based industry in the Middle East through harnessing the potential of the Red Sea biodiversityImproving thermal hysteresis activity of antifreeze protein from recombinant Pichia pastoris by removal of N-glycosylation.Sucrose and Saccharomyces cerevisiae: a relationship most sweet.Generally Applicable Transformation Protocols for Fluorescent Nanodiamond Internalization into Cells.Biomedical applications of yeast- a patent view, part one: yeasts as workhorses for the production of therapeutics and vaccines.Production of valuable compounds by molds and yeasts.Engineering yeast for producing human glycoproteins: where are we now?EasyClone 2.0: expanded toolkit of integrative vectors for stable gene expression in industrial Saccharomyces cerevisiae strains.Systematic Optimization of Protein Secretory Pathways in Saccharomyces cerevisiae to Increase Expression of Hepatitis B Small Antigen.Molecular design for recombinant adeno-associated virus (rAAV) vector production.Impact of plasmid architecture on stability and yEGFP3 reporter gene expression in a set of isomeric multicopy vectors in yeast.POT1-mediated δ-integration strategy for high-copy, stable expression of heterologous proteins in Saccharomyces cerevisiae.Platforms for Recombinant Therapeutic Glycoprotein Production.Sophisticated lessons from simple organisms: appreciating the value of curiosity-driven research.Genetic and physiological basis for antibody production by Kluyveromyces marxianus.Balanced trafficking between the ER and the Golgi apparatus increases protein secretion in yeast.The impact of respiration and oxidative stress response on recombinant α-amylase production by Saccharomyces cerevisiae.Comparison of Yeasts as Hosts for Recombinant Protein Production.Production and Purification of Recombinant Proteins fromEscherichia coliValuation of agro-industrial wastes as substrates for heterologous production of α-galactosidase
P2860
Q26799506-120E2A3A-C160-41F0-80F6-7313CCD88768Q27000550-DC029F64-2259-4622-8A5C-40E003C776F6Q30234979-79FECAE1-7D54-4C6E-B0BF-E484E8355BCFQ34264451-BDC4E7CE-D758-4CB0-BC72-2CF45F24015EQ34718110-A3CE3AF0-92C5-4424-9C49-ABC09E4F901CQ36377114-37DC3BFF-DE4E-405A-9310-CFAF3E9CC965Q38290647-704C4784-D22B-4AA9-9EC5-4EDB31CDCF09Q38666676-50F1591F-6062-4878-854B-EC62F51CF794Q38671363-3A39438F-0D65-4741-94B1-97552D578F08Q38671575-D4384442-C218-4E6F-8A76-5EDD935EC793Q38812487-6C722856-889B-4FD1-9844-292F1FA83813Q39055068-56456924-0C4E-451C-89AE-26726C5BD205Q41775382-306625A9-0D5F-4584-8FE4-EAC0D631A68FQ41866687-35FD2AAA-8BC4-4110-99F9-49CA1D69307EQ45323804-651F6124-B58E-4856-9F87-6B5EE67E56B6Q47095086-D93AC737-9A12-4530-BC68-16D483D814C1Q47662764-E06FAC62-AA3A-4E83-B446-5A9E92C7BA66Q47786965-1CD055D8-3095-47B1-9340-2FBF44E13975Q48092080-9BB107C7-4A73-4027-96EB-DD055D40E83AQ52431529-09EB498D-958E-49D8-A8E4-1801E2D2E606Q55048961-49B5BDFF-9FBF-4290-A96E-5999814BA2B8Q55669091-8F25074A-E5A0-4519-96C6-49001C2CF11DQ55717914-147A2988-9FA2-41ED-988F-E7BD1322DE60Q56960737-15974AF5-F328-4CCA-A77C-819D5D3506E0Q58768211-6F963A9B-0608-4AD8-8869-8583B476901F
P2860
Production of biopharmaceutical proteins by yeast: advances through metabolic engineering.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Production of biopharmaceutica ...... through metabolic engineering.
@ast
Production of biopharmaceutica ...... through metabolic engineering.
@en
Production of biopharmaceutica ...... through metabolic engineering.
@nl
type
label
Production of biopharmaceutica ...... through metabolic engineering.
@ast
Production of biopharmaceutica ...... through metabolic engineering.
@en
Production of biopharmaceutica ...... through metabolic engineering.
@nl
prefLabel
Production of biopharmaceutica ...... through metabolic engineering.
@ast
Production of biopharmaceutica ...... through metabolic engineering.
@en
Production of biopharmaceutica ...... through metabolic engineering.
@nl
P2860
P921
P356
P1433
P1476
Production of biopharmaceutica ...... through metabolic engineering.
@en
P2860
P304
P356
10.4161/BIOE.22856
P50
P577
2012-11-12T00:00:00Z